This from the website of Rettsyndrome.org, the US-based fund raising body that has backed the Neuren trials and has taken an equity stake in the company...
"Strategic partnerships with pharmaceutical companies have allowed us to bring the first and only treatment compound for Rett syndrome into the final phase of clinical testing. When this treatment becomes prescribable, it will revolutionize the daily lives of children with Rett syndrome."
I particularly like the use of 'when' and not 'if' - they sound pretty confident.
GLTAH
https://www.rettsyndrome.org/make-a-difference/donate/research-to-reality
Ann: Neuren announces new US patent to be granted for NNZ-2591, page-87
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |